CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fowler, L.
Right arrow Articles by Jaken, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fowler, L.
Right arrow Articles by Jaken, S.

Cell Growth & Differentiation, Vol 9, Issue 5 405-413, Copyright © 1998 by American Association of Cancer Research


ARTICLES

Redistribution and enhanced protein kinase C-mediated phosphorylation of alpha- and gamma-adducin during renal tumor progression

L Fowler, J Everitt, JL Stevens and S Jaken
Adirondack Biomedical Research Institute, Lake Placid, New York 12946, USA.

Tumor promotion/progression is known to be due in part to increased signaling through a variety of mitogenic pathways, including protein kinase C (PKC). To determine whether increased PKC activity could play a role in promotion and progression of renal cancer, we monitored PKC activity in normal and progressively transformed renal neoplasias from Eker rats. Eker rats carry a defect in the tumor suppressor TSC2 gene that predisposes them to renal carcinoma, whereas additional factors influence tumor promotion/progression in accordance with a "two-hit" model. We used the phosphorylation of adducins at Ser-660, a known PKC phosphorylation site, as a reporter for endogenous PKC activity. In normal proximal tubules, total adducin levels (measured with a phosphorylation state-insensitive antibody) were relatively high, whereas pSer660-adducin (measured with a phosphorylation state-sensitive antibody) levels were very low. In comparison, in renal carcinomas, total adducin levels were decreased, and pSer-660-adducin levels were increased. Changes in phosphorylation correlated with changes in localization. In normal tissue, alpha- and gamma-adducin are targeted to the apical and basal membranes of proximal tubules, respectively, implying unique functions for these related proteins. In early lesions (atypical tubules), differential targeting is lost, and both alpha- and gamma-adducins localize to the basal membrane. In more advanced lesions, staining in lateral membranes at cell-cell contacts becomes apparent. Furthermore, in cells that have lost basement membrane contact, plasma membrane targeting is no longer apparent. These changes in adducin expression levels, phosphorylation state, and localization parallel the increased growth potential and dedifferentiation of the progressive tumor phenotypes. These data demonstrate the utility of phosphorylation state-selective antibodies in immunohistochemical applications as reporters of endogenous PKC activity in tissue samples. We also provide the first evidence that increased PKC activity and phosphorylation of important target proteins occurs during progressive transformation in a non-phorbol ester tumor promotion model in vivo.


This article has been cited by other articles:


Home page
Anticancer ResHome page
M.-W. POON, J. T. F. ZHUANG, S. T. S. WONG, S. SUN, X.-Q. ZHANG, and G. K. K. LEUNG
Co-expression of Cytoskeletal Protein Adducin 3 and CD133 in Neurospheres and a Temozolomide-resistant Subclone of Glioblastoma
Anticancer Res, December 1, 2015; 35(12): 6487 - 6495.
[Abstract] [Full Text] [PDF]


Home page
Biology OpenHome page
S. J. H. Wang, A. Tsai, M. Wang, S. Yoo, H.-y. Kim, B. Yoo, V. Chui, M. Kisiel, B. Stewart, W. Parkhouse, et al.
Phospho-regulated Drosophila adducin is a determinant of synaptic plasticity in a complex with Dlg and PIP2 at the larval neuromuscular junction
Biology Open, December 15, 2014; 3(12): 1196 - 1206.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. Dimke, P. San-Cristobal, M. de Graaf, J. W. Lenders, J. Deinum, J. G. J. Hoenderop, and R. J. M. Bindels
{gamma}-Adducin Stimulates the Thiazide-sensitive NaCl Cotransporter
J. Am. Soc. Nephrol., March 1, 2011; 22(3): 508 - 517.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H.-D. Je, C. Gallant, P. C. Leavis, and K. G. Morgan
Caveolin-1 regulates contractility in differentiated vascular smooth muscle
Am J Physiol Heart Circ Physiol, December 17, 2003; 286(1): H91 - H98.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Alt, M. Ohba, L. Li, M. Gartsbein, A. Belanger, Mitchell. F. Denning, T. Kuroki, S. H. Yuspa, and T. Tennenbaum
Protein Kinase C{{delta}}-mediated Phosphorylation of {{alpha}}6{beta}4 Is Associated with Reduced Integrin Localization to the Hemidesmosome and Decreased Keratinocyte Attachment
Cancer Res., June 1, 2001; 61(11): 4591 - 4598.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. A. Sausville, S. G. Arbuck, R. Messmann, D. Headlee, K. S. Bauer, R. M. Lush, A. Murgo, W. D. Figg, T. Lahusen, S. Jaken, et al.
Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
J. Clin. Oncol., April 15, 2001; 19(8): 2319 - 2333.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
B. van de Water, I. B. Tijdens, A. Verbrugge, M. Huigsloot, A. A. Dihal, J. L. Stevens, S. Jaken, and G. J. Mulder
Cleavage of the Actin-capping Protein {alpha}-Adducin at Asp-Asp-Ser-Asp633-Ala by Caspase-3 Is Preceded by Its Phosphorylation on Serine 726 in Cisplatin-induced Apoptosis of Renal Epithelial Cells
J. Biol. Chem., August 18, 2000; 275(33): 25805 - 25813.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. RON and M. G. KAZANIETZ
New insights into the regulation of protein kinase C and novel phorbol ester receptors
FASEB J, October 1, 1999; 13(13): 1658 - 1676.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. C. Kiley, K. J. Clark, M. Goodnough, D. R. Welch, and S. Jaken
Protein Kinase C {{delta}} Involvement in Mammary Tumor Cell Metastasis
Cancer Res., July 1, 1999; 59(13): 3230 - 3238.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. Chapline, J. Cottom, H. Tobin, J. Hulmes, J. Crabb, and S. Jaken
A Major, Transformation-sensitive PKC-binding Protein Is Also a PKC Substrate Involved in Cytoskeletal Remodeling
J. Biol. Chem., July 31, 1998; 273(31): 19482 - 19489.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
B. van de Water, I. B. Tijdens, A. Verbrugge, M. Huigsloot, A. A. Dihal, J. L. Stevens, S. Jaken, and G. J. Mulder
Cleavage of the Actin-capping Protein {alpha}-Adducin at Asp-Asp-Ser-Asp633-Ala by Caspase-3 Is Preceded by Its Phosphorylation on Serine 726 in Cisplatin-induced Apoptosis of Renal Epithelial Cells
J. Biol. Chem., August 18, 2000; 275(33): 25805 - 25813.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1998 by the American Association of Cancer Research.